Kun Yu

731 total citations
17 papers, 501 citations indexed

About

Kun Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kun Yu has authored 17 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Kun Yu's work include Breast Cancer Treatment Studies (5 papers), Gene expression and cancer classification (5 papers) and HER2/EGFR in Cancer Research (3 papers). Kun Yu is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Gene expression and cancer classification (5 papers) and HER2/EGFR in Cancer Research (3 papers). Kun Yu collaborates with scholars based in Singapore, China and Japan. Kun Yu's co-authors include Patrick Tan, Puay Hoon Tan, Kumaresan Ganesan, Lance D. Miller, Jeanie Wu, Chia Lin Wei, Xiao Dong Zhao, Mirtha Laban, Shing Chuan Hooi and Yansong Zhu and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Human Molecular Genetics.

In The Last Decade

Kun Yu

15 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Yu Singapore 10 322 197 192 62 55 17 501
Huawei Zou China 16 403 1.3× 322 1.6× 244 1.3× 70 1.1× 52 0.9× 36 710
Jennifer M. Shipman United States 11 378 1.2× 123 0.6× 128 0.7× 120 1.9× 24 0.4× 13 539
Martina Vetter Germany 14 384 1.2× 341 1.7× 206 1.1× 41 0.7× 43 0.8× 44 629
Fawaz Halwani Canada 11 260 0.8× 108 0.5× 195 1.0× 55 0.9× 37 0.7× 16 522
Mitsuhiro Hishida Japan 12 309 1.0× 152 0.8× 91 0.5× 44 0.7× 44 0.8× 23 484
Merete Bjørnslett Norway 11 292 0.9× 121 0.6× 238 1.2× 118 1.9× 44 0.8× 20 530
Alexis de Haven Brandon United Kingdom 12 424 1.3× 122 0.6× 179 0.9× 54 0.9× 25 0.5× 22 595
Tomohiko Harada Japan 12 272 0.8× 214 1.1× 272 1.4× 56 0.9× 116 2.1× 16 539
Takaaki Imamura Japan 12 351 1.1× 182 0.9× 181 0.9× 75 1.2× 32 0.6× 24 647
Guermarie Velázquez-Torres United States 13 508 1.6× 182 0.9× 302 1.6× 29 0.5× 23 0.4× 14 709

Countries citing papers authored by Kun Yu

Since Specialization
Citations

This map shows the geographic impact of Kun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Yu more than expected).

Fields of papers citing papers by Kun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Yu. The network helps show where Kun Yu may publish in the future.

Co-authorship network of co-authors of Kun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Yu. A scholar is included among the top collaborators of Kun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Yu. Kun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Yu‐Chuan, Yiming Sun, Kun Yu, et al.. (2025). Keratin: A potential driver of tumor metastasis. International Journal of Biological Macromolecules. 307(Pt 1). 141752–141752. 1 indexed citations
2.
Zhong, Guansheng, et al.. (2024). CPSF4-mediated regulation of alternative splicing of HMG20B facilitates the progression of triple-negative breast cancer. Journal of Translational Medicine. 22(1). 1149–1149.
3.
Fasano, Alfonso, Claire Henchcliffe, Harini Sarva, et al.. (2024). Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study. Parkinsonism & Related Disorders. 122. 106129–106129.
4.
Li, Mingying, Ying Xin, Miao Liu, & Kun Yu. (2021). Platelet-derived exosomes promote the epithelial–mesenchymal transition in MCF7 cells. Molecular & Cellular Toxicology. 18(1). 31–37. 2 indexed citations
5.
Yu, Kun, Ying Xin, Kexin Meng, et al.. (2021). Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA SignatureMight be a Potential Biomarker for Predicting the Prognosis of PapillaryThyroid Carcinoma. Combinatorial Chemistry & High Throughput Screening. 25(5). 819–830. 9 indexed citations
6.
7.
8.
9.
Omar, Mohd Feroz Mohd, Ning Huang, Keli Ou, et al.. (2009). Molecular-assisted immunohistochemical optimization. Acta Histochemica. 112(6). 519–528. 5 indexed citations
10.
Yu, Kun, Kumaresan Ganesan, Mirtha Laban, et al.. (2008). A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers. PLoS Genetics. 4(7). e1000129–e1000129. 118 indexed citations
11.
Huynh, Hung, Pierce K. H. Chow, Nallasivam Palanisamy, et al.. (2008). Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. Journal of Hepatology. 49(1). 52–60. 61 indexed citations
12.
Tan, Benita Kiat Tee, Kun Yu, Puay Hoon Tan, et al.. (2008). Clinical Validation of a Customized Multiple Signature Microarray for Breast Cancer. Clinical Cancer Research. 14(2). 461–469. 12 indexed citations
13.
Yu, Kun, Kumaresan Ganesan, Lance D. Miller, & Patrick Tan. (2006). A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor–Positive Tumors. Clinical Cancer Research. 12(11). 3288–3296. 32 indexed citations
14.
Ou, Keli, Djohan Kesuma, Kumaresan Ganesan, et al.. (2006). Quantitative Profiling of Drug-Associated Proteomic Alterations by Combined 2-Nitrobenzenesulfenyl Chloride (NBS) Isotope Labeling and 2DE/MS Identification. Journal of Proteome Research. 5(9). 2194–2206. 34 indexed citations
15.
Yu, Kun, et al.. (2004). Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations. Clinical Cancer Research. 10(16). 5508–5517. 91 indexed citations
16.
Yu, Kun, et al.. (2004). A Molecular Signature of the Nottingham Prognostic Index in Breast Cancer. Cancer Research. 64(9). 2962–2968. 54 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huawei Zou Breakdown of academic impact, for papers by Jennifer M. Shipman Breakdown of academic impact, for papers by Martina Vetter Breakdown of academic impact, for papers by Fawaz Halwani Breakdown of academic impact, for papers by Mitsuhiro Hishida Breakdown of academic impact, for papers by Merete Bjørnslett Breakdown of academic impact, for papers by Alexis de Haven Brandon Breakdown of academic impact, for papers by Tomohiko Harada Breakdown of academic impact, for papers by Takaaki Imamura Breakdown of academic impact, for papers by Guermarie Velázquez-Torres
Rankless by CCL
2026